A-10 ""murine models of lung infection - antibiotic-resistant pseudomonas aeruginosa"

Ended Awarded Last action

Contract number
75N93018F00003
Awardee
Awarding agency
Obligated
$506,429

Award facts

Opportunity
  • NIHAI2016059 Solicitation number
Contract value 100% obligated
$506,429.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20851, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00010 · To DE-obligate remaining funds and administratively close the task order. -$51,585
Funding Only Action P00009 · DE-obligation FY'2018 funds in the amount of $46,581.00. -$46,581
Other Administrative Action P00008 · Extend options 4A and 4B completion period from may 2, 2020 to may 29, 2020. May 13, 2020 to june 5, 2020 for options 4C and 4D $0
Other Administrative Action P00007 · This modification will extend the option 3 completion period from april 30, 2020 to may 29, 2020. $0
Exercise an Option P00006 · To exercise option 4C and 4D under task order HHSN27200003 (a-10) entitled, "murine models of lung infection - antibiotic-resistant pseudomonas aeruginosa" $28,608
Exercise an Option P00005 · To exercise option 4A and 4B under task order HHSN27200003 (a-10) entitled, "murine models of lung infection - antibiotic-resistant pseudomonas aeruginosa" $28,608
Exercise an Option P00004 · To exercise options 2 and 3 under task order HHSN27200003 (a-10) entitled, "murine models of lung infection - antibiotic-resistant pseudomonas aeruginosa" $160,514
Exercise an Option P00003 · To exercise option 1C under task order HHSN27200003 (a-10) entitled, "murine models of lung infection - antibiotic-resistant pseudomonas aeruginosa" $21,510
Exercise an Option P00001 $0
Exercise an Option P00002 · To exercise option 1A and 1B under task a-10 "murine models of lung infection - antibiotic-resistant pseudomonas aeruginosa" $43,020
Original award $322,335
Show all 11

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on June 5, 2018, with a ceiling value of $506,429, to develop murine models of lung infection caused by antibiotic-resistant Pseudomonas aeruginosa as preclinical models for infectious disease research. The order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ.

Place of performance is Rockville, MD. The ultimate completion date is August 15, 2023. Pricing is Cost Plus Fixed Fee. In FY2020, the order generated $303 thousand in government-invoiced labor, which Pharmacology Discovery Services Taiwan self-performed with no subcontractors reported.

Quick answers

Who was awarded contract 75N93018F00003?

75N93018F00003 was awarded to Pharmacology Discovery Services Taiwan, LTD. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 5, 2018.

How much is contract 75N93018F00003 worth?

The government has obligated $506,429 on 75N93018F00003.

Is contract 75N93018F00003 an order under another contract?

Yes. 75N93018F00003 is a delivery order under HHSN272201700020I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.

Was contract 75N93018F00003 competed?

The extent of competition for 75N93018F00003 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login